Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STEPHEN R ELLIS

Allopathic & Osteopathic Physicians Anesthesiology

NPI
1861455719
CMS profile
957366
Location
DALLAS, TX

General Payments · PY2018–2024

$2,664.30

  • Reported across 62 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$551.04

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $551.04 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
REVANCE THERAPEUTICS, INC. $484.93 12
MERZ NORTH AMERICA, INC. $44.61 2
Lilly USA, LLC $21.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $19.43 1
PY2019 $42.00 2
PY2020 $15.34 1
PY2021 $383.78 9
PY2022 $544.76 10
PY2023 $1,107.95 24
PY2024 $551.04 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Lilly USA, LLC $21.50 09/16/2024 Food and Beverage Undisputed 01/23/2026 1135427126 CMS
MERZ NORTH AMERICA, INC. $19.13 10/07/2024 Food and Beverage Undisputed 01/23/2026 1146375412 CMS
MERZ NORTH AMERICA, INC. $25.48 12/16/2024 Food and Beverage Undisputed 01/23/2026 1146375410 CMS
REVANCE THERAPEUTICS, INC. $29.48 02/28/2024 Food and Beverage Undisputed 01/23/2026 1147917145 CMS
REVANCE THERAPEUTICS, INC. $83.33 04/03/2024 Food and Beverage Undisputed 01/23/2026 1147917147 CMS
REVANCE THERAPEUTICS, INC. $6.15 04/30/2024 Food and Beverage Undisputed 01/23/2026 1147917149 CMS
REVANCE THERAPEUTICS, INC. $31.63 05/06/2024 Food and Beverage Undisputed 01/23/2026 1147917151 CMS
REVANCE THERAPEUTICS, INC. $48.75 05/06/2024 Food and Beverage Undisputed 01/23/2026 1147917153 CMS
REVANCE THERAPEUTICS, INC. $52.53 08/05/2024 Food and Beverage Undisputed 01/23/2026 1147917155 CMS
REVANCE THERAPEUTICS, INC. $148.60 08/13/2024 Food and Beverage Undisputed 01/23/2026 1147917157 CMS
REVANCE THERAPEUTICS, INC. $21.63 09/11/2024 Food and Beverage Undisputed 01/23/2026 1147917159 CMS
REVANCE THERAPEUTICS, INC. $10.11 11/07/2024 Food and Beverage Undisputed 01/23/2026 1147917161 CMS
REVANCE THERAPEUTICS, INC. $9.50 11/07/2024 Food and Beverage Undisputed 01/23/2026 1147917163 CMS
REVANCE THERAPEUTICS, INC. $23.79 12/12/2024 Food and Beverage Undisputed 01/23/2026 1147917165 CMS
REVANCE THERAPEUTICS, INC. $19.43 12/13/2024 Food and Beverage Undisputed 01/23/2026 1147917167 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.